文献速递腹部外周血管CT

能谱CT评估布加综合征患者肝功能的临床效能

Clinical Efficacy of Spectral Computed Tomography for Evaluating Liver Function in Patients with Budd-Chiari Syndrome.
PubMed 文献 · Acad Radiol · 2018-08-09

本研究分析41例布加综合征(BCS)患者治疗前后能谱CT定量参数与肝功能的相关性,发现治疗后有肝段碘浓度升高,且肝功能Child-Pugh C级患者升高更明显,提示能谱CT碘浓度有助于评估BCS患者肝功能,为复查、预后评估和随访提供影像数据。

要点

  • 能谱CT门静脉期肝段碘浓度(NIC)与肝功能指标相关:PT、TBIL与NIC负相关,ALB与NIC正相关。
  • BCS治疗后肝段I-VIII的NIC均较治疗前升高,其中II-VIII段差异有统计学意义(p均<0.05)。
  • 肝功能Child-Pugh C级患者治疗前后NIC升高幅度较B级和A级更明显。

核心结论

  • 能谱CT测定的NIC有助于评估BCS患者肝功能,可为治疗后复查、预后评估和随访提供影像数据。
  • 不同肝功能分级BCS患者的肝实质NIC值可能具有一定诊断价值。
  • 能谱CT多部位、多参数研究有助于进一步评估BCS患者肝功能和判断预后。

研究设计与样本

  • 研究纳入2015年12月至2017年3月确诊的41例BCS患者,获取血管造影数据。
  • 所有患者于BCS治疗前后行能谱CT检查,两次扫描平均间隔2-4个月。
  • 于门静脉期测量并计算肝段I-VIII的碘浓度和NIC,同时记录PT、ALB、TBIL、AST和ALT等临床肝功能指标。
  • 按Child-Pugh分级标准(治疗前)对肝功能进行分级。
  • 采用配对t检验比较治疗前后肝NIC及肝功能相关参数,采用Pearson相关分析分析治疗前不同肝功能分级间上述参数的相关性,以p<0.05为差异有统计学意义。

诊断标准与关键数值

  • PT和TBIL与肝NIC呈负相关(p<0.05),ALB与肝NIC呈正相关(p<0.05)。
  • 治疗后肝段I-VIII的NIC均较治疗前升高,其中II-VIII段的p值分别为0.041、0.046、0.041、0.038、0.039、0.042和0.040,差异有统计学意义(p<0.05)。
  • 肝功能Child-Pugh C级患者治疗前后肝段I-VIII的NIC升高幅度较B级和A级患者更明显。
  • 治疗后PT缩短,ALB水平升高,TBIL、ALT和AST水平降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To analyze the clinical relevance of quantitative spectral parameters in evaluating the treatment of patients with Budd-Chiari syndrome (BCS) with different classes of liver function by comparing normalized iodine concentration (NIC) before and after BCS treatment.

MATERIALS AND METHODS: Angiographic data were obtained from 41 patients with confirmed BCS between December 2015 and March 2017. All patients underwent spectral computed tomography (CT) before and after BCS treatment; the average interval between scans was 2-4 months. Iodine concentration and NIC were measured and calculated during the portal venous phase in liver segments I-VIII. Clinical liver function parameters including prothrombin time (PT), albumin (ALB), total bilirubin (TBIL), aspartate aminotransferase, and alanineaminotransferase were recorded. Liver function was classified according to the Child-Pugh grading standard (before treatment). Liver NIC and liver function-related parameters before and after treatment were compared using the paired t-test; Pearson correlation analysiswas performed to analyze the aforementioned parameters among different liver function classes before BCS treatment. p < 0.05 was to be statistically considered significant.

RESULTS: PT and TBIL were negatively correlated with liver NIC (p < 0.05), whereas ALB and liver NIC exhibited a positive correlation (p < 0.05). Comparison of NIC before and after treatment revealed that NIC in liver segments I-VIII was higher after treatment. The p values for segments II-VIII were 0.041, 0.046, 0.041, 0.038, 0.039, 0.042, and 0.040, respectively; the differences were statistically significant (p < 0.05). The increase in NIC in liver segments I-VIII before and after treatment was more significant in patients with class C liver function than in their class B and A counterparts. Comparison of liver function-related parameters revealed that PT was shortened after treatment; ALB levels were increased; and TBIL, alanine aminotransferase, and aspartate aminotransferase levels were decreased.

CONCLUSION: NIC determined through spectral CT was beneficial for evaluating liver function in patients with BCS, and can provide imaging data for reexamination, prognostic evaluation, and follow-up of patients with BCS after treatment. Liver parenchyma NIC values in BCS patients with varying liver function may provide a degree of diagnostic value. Multi-locus and multi-parameter studies of spectral CT can help to further evaluate liver function and assess prognosis in patients with BCS.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Su L, Hu L, Liang P, et al. Clinical Efficacy of Spectral Computed Tomography for Evaluating Liver Function in Patients with Budd-Chiari Syndrome. Acad Radiol. 2018. PMID: 30098862. doi:10.1016/j.acra.2018.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。